TERMINATION AGREEMENTTermination Agreement • August 13th, 2015 • Oncogenex Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledAugust 13th, 2015 Company Industry JurisdictionThis Termination Agreement (the “Agreement”) is made and entered into as of the 24th day of April, 2015 (the “Closing Date”), by and between OncoGenex Technologies, Inc. (“OGX”) and Teva Pharmaceutical Industries Ltd. (“Teva”). OGX and Teva are referred to herein collectively as the “Parties” and individually as a “Party.”